The FDA has released a draft document entitled “Guidance for Industry: Current Good Tissue Practice (CGTP) and Additional Requirements for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps).” The draft document provides establishments that manufacture HCT/Ps with recommendations for complying with CGTP requirements. This guidance also addresses whether the establishment registration and HCT/P listing requirements under 21 CFR part 1271, subparts A and B apply in certain instances. The FDA will accept comments on the guidance through April 16, 2009.
Register now for your free, tailored, daily legal newsfeed service.
Questions? Please contact customerservices@lexology.com
RegisterIf you would like to learn how Lexology can drive your content marketing strategy forward, please email enquiries@lexology.com.
Leverage your legal knowledge
With the legal sector working digitally, it's a great time to review your current content marketing strategy and see where you can get the best ROI from your existing content.
Related topic hubs
Don Sangster
Legal Department Administrator
Jovian Capital Corporation
What our clients say
”Lexology is a useful and informative tool. I keep copies of relevant articles and often forward them to colleagues. Although I do not know all of the authors/firms, by reading their articles I do gain an understanding of their appreciation of a topic, and should the need arise I would not hesitate to contact them on those topics.”